NCCN Guidelines Update Webinar Series™ Kidney Cancer program overview - UroToday PDF Print
UroTodayWith the FDA approvals of new agents for renal cell carcinoma, a paradigm shift has occurred in the way patients with renal cell carcinomas are treated.

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.